MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Interventions"

  • 2016 International Congress

    Coping styles and their influence on outcomes in Parkinson’s disease

    K.M. Sundvick, F. Kassam, N. Dispirito, E. Book, S. Cresswell (Vancovuer, BC, Canada)

    Objective: To understand the associations between coping styles and various clinical symptoms and outcomes in patients with Parkinson's disease (PD). Background: The diagnosis of a…
  • 2016 International Congress

    Rotigotine transdermal patch in Chinese patients with advanced Parkinson’s disease: A randomized, double-blind study

    Z. Zhang, M. Asgharnejad, H. Xue, E. Surmann, L. Bauer (Beijing, People's Republic of China)

    Objective: A multicenter phase III study (SP1037; NCT01646255) to investigate the efficacy and safety of rotigotine in Chinese patients with advanced Parkinson's disease (PD). Background:…
  • 2016 International Congress

    Eight weeks of home-based balance training not as effective as therapist-based during dual tasks

    E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)

    Objective: To assess the effect of balance training on dual-tasking gait, and to investigate if a home-based programme is comparable to a therapist-supervised programme. Background:…
  • 2016 International Congress

    Suggested criteria for patient selection for therapy with carbidopa/levodopa enteral suspension (CLES)

    R.L. Rodriguez, T. Green, F. Rossi, A. Khaku, J. Slevin (Orlando, FL, USA)

    Objective: To provide suggested guidance on how to select appropriate candidates for therapy with carbidopa/levodopa enteral suspension (CLES) based on published literature. Background: The introduction…
  • 2016 International Congress

    Comparison of four DBS lead designs under voltage and current operating modes based on patient specific simulations

    F. Alonso, N. Göransson, P. Zsgimond, K. Wårdell (Linköping, Sweden)

    Objective: To quantitatively compare the spatial extension of the electric field generated by four different lead designs operated under voltage and current modes. Background: Conventional…
  • 2016 International Congress

    Safety and clinical effects of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson’s disease (PD): 81 to 130 weeks follow-up

    B.J. Snow, E. Mulroy, M. Simpson, L. Macdonald, A. Bok, K. Taylor, J. Han, K. Durbin (Auckland, New Zealand)

    Objective: To follow the clinical status of 4 PD patients transplanted with NTCELL out to 81-130 weeks. Background: NTCELL comprises neonatal porcine choroid plexus cells…
  • 2016 International Congress

    Wearable sensors and decision algorithms for advanced therapy referral in Parkinson’s disease

    D.A. Heldman, J.P. Giuffrida, E. Cubo (Cleveland, OH, USA)

    Objective: Pilot study to determine the impact of remote monitoring using objective, wearable sensors on the advanced therapy referral rate in patients with advanced Parkinson's…
  • 2016 International Congress

    Pathological findings from two Parkinson’s disease patients after intraputaminal GDNF infusion

    T.R. Yamasaki, V.D. Smith, Y. Ai, D.M. Gash, P.T. Nelson, G.A. Gerhardt, J.T. Slevin (Lexington, KY, USA)

    Objective: To describe the postmortem findings from two patients who underwent intraputaminal infusion of glial-derived neurotrophic factor (GDNF). Background: GDNF has been shown to have…
  • 2016 International Congress

    Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson’s patients

    T.E. Tong, M.L. Ng, N. Yan (Hong Kong, Hong Kong)

    Objective: The current study adopted a randomized control trial (RCT) design to investigate the impact of expiratory muscle strength training (EMST) on vocal loudness and…
  • 2016 International Congress

    A clinical trials ‘charter’ to improve communication about, recruitment to and retention in Parkinson’s clinical trials

    C. Carroll, I. Tom, M. Helen, S. Jon (Plymouth, United Kingdom)

    Objective: The objective of the project was to design a durable tool, usable by clinical trial investigators and participants alike, that would improve subject retention…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley